• Proteomic Impact of HSP90 Inhibition in Lung Adenocarcinoma

  2026-04-22

  This study systematically profiles proteomic alterations in lung adenocarcinoma cells following pharmacological HSP90 inhibition, revealing pathways and biomarkers implicated in therapeutic response. The findings underscore the interplay between HSP90 and co-chaperones like HSP70, informing the design of multi-chaperone targeting strategies in cancer research.

• Ellagic Acid: Applied CK2 Inhibition for Cancer Biology Rese

  2026-04-22

  Harness ellagic acid as a precision tool to dissect casein kinase 2 signaling and oxidative stress in cancer biology. This article details robust workflows, troubleshooting strategies, and insights from AI-driven senolytic discovery, setting your research apart with rigor and reproducibility.

• Icariin Regulates SSC Proliferation and DNA Damage via PDE5A

  2026-04-21

  This study elucidates how Icariin, a compound from traditional Chinese medicine, enhances proliferation and DNA synthesis in mouse spermatogonial stem cells (SSCs) by targeting PDE5A. The findings provide mechanistic insight into male fertility regulation and offer a foundation for translational approaches in male infertility treatment.

• Structural Basis of HCAR3-Selective Agonist Recognition Reve

  2026-04-21

  The referenced study provides the first high-resolution cryo-EM structures of HCAR3 in complex with selective agonists, including Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid). These insights clarify the molecular determinants of ligand binding and specificity, laying a foundation for rational design of hypolipidemic agents targeting lipid metabolism without HCAR2-associated side effects.

• Antibacterial Drug Use and Bacterial Resistance in Psychiatr

  2026-04-20

  This study analyzes antibacterial drug usage and bacterial resistance patterns in a psychiatric hospital during the 2022 COVID-19 epidemic. The findings highlight rational antibiotic use but underscore the need for enhanced resistance monitoring to optimize patient outcomes and prevent the proliferation of drug-resistant strains.

• Filamin A Suppression Boosts HEV Replication via NF-κB Pathw

  2026-04-20

  This study uncovers how hepatitis E virus (HEV) enhances its replication by suppressing filamin A (FLNa), thereby inhibiting NF-κB signaling. The findings reveal cytoskeletal remodeling as a viral strategy to evade innate immunity and highlight new antiviral research directions.

• Encapsulating mRNA in MOFs: Advancing Gene Delivery Stabilit

  2026-04-19

  This study demonstrates a synthetic approach for encapsulating and delivering mRNA using zeolitic imidazole framework-8 (ZIF-8) metal-organic frameworks, addressing the longstanding challenge of mRNA instability in biological media. By introducing polyethyleneimine (PEI) into the ZIF-8 matrix, the authors enable improved mRNA retention, cellular delivery, and sustained protein expression, expanding the possibilities for non-viral gene delivery platforms.

• RWJ 67657: Selective p38 MAP Kinase Inhibitor in Inflammatio

  2026-04-18

  RWJ 67657 (JNJ-3026582) is redefining experimental workflows in inflammatory disease research by delivering highly selective, dual-action inhibition of p38α/β MAP kinases. Its unique mechanism streamlines TNF-alpha suppression, supports reproducible cytokine modulation, and enables advanced insights into immune signaling pathways.

• 3-Aminobenzamide (PARP-IN-1): Potent PARP Inhibitor Profilin

  2026-04-17

  3-Aminobenzamide (PARP-IN-1) is a potent and selective poly (ADP-ribose) polymerase (PARP) inhibitor with a nanomolar IC50. It enables precise modulation of PARP activity in cellular and disease models, supporting research in oxidative stress and diabetic nephropathy. This article reviews the compound’s mechanism, benchmarks, and integration into experimental workflows with evidence-backed clarity.

• PD 173074: Precision FGFR1/VEGFR2 Inhibition in Cancer Resea

  2026-04-16

  PD 173074 stands out as a highly selective, nanomolar-potency FGFR1/VEGFR2 inhibitor, equipping researchers to dissect angiogenesis, tumor progression, and resistance mechanisms in both in vitro and in vivo models. This article offers actionable workflows, advanced troubleshooting, and protocol enhancements, directly integrating recent translational findings and best practices.

• HyperFluor™ 488 Goat Anti-Human IgG: Quantitative Immunoassa

  2026-04-15

  Explore how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody unlocks new frontiers in quantitative immunodetection. This deep dive reveals its scientific underpinnings, unique workflow optimizations, and lessons drawn from cutting-edge vaccine research for highly sensitive, reproducible assays.

• Indomethacin Sodium Trihydrate: Advanced Remyelination Insig

  2026-04-14

  Explore the multifaceted role of Indometacin Sodium in neuroregeneration and inflammation assay design. This article uniquely analyzes endogenous remyelination mechanisms and practical assay guidance, providing new depth for anti-inflammatory research.

• Anti-Fibrotic Activity of 1-Phenyl-2-Pentanol in Hepatic Ste

  2026-04-13

  The referenced study demonstrates that 1-phenyl-2-pentanol, isolated from Moringa oleifera, suppresses hepatic stellate cell activation and fibrosis marker expression by modulating TGF-β1 and Wnt/β-catenin signaling. This work identifies a new plant-derived candidate for anti-fibrotic therapy and provides mechanistic insight for future liver fibrosis research.

• Okadaic Acid (A4540): Practical Protocols for Phosphatase In

  2026-04-13

  Okadaic acid is a well-characterized inhibitor of protein phosphatase 1 (PP1) and 2A (PP2A), enabling reliable dissection of phosphorylation-dependent signaling and apoptosis in research models. It is best suited for workflows requiring precise control of serine/threonine phosphatase activity, but is not recommended for use outside established cell and molecular biology applications due to its potent and broad enzymatic effects.

• EdU Flow Cytometry Assay Kits (Cy3): Precision in Cell Cycle

  2026-04-12

  Explore the scientific foundations and unique advantages of EdU Flow Cytometry Assay Kits (Cy3) for cell proliferation studies, with a focus on rigorous cell cycle analysis and insight from pan-cancer research. Learn how this assay advances beyond conventional methods and supports cutting-edge biomedical applications.

15624 records 1/1042 page Next 12345 下5页 Last page